588 related articles for article (PubMed ID: 19808352)
41. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.
Kelly D; Squire IB; Khan SQ; Quinn P; Struck J; Morgenthaler NG; Davies JE; Ng LL
J Card Fail; 2008 Nov; 14(9):739-45. PubMed ID: 18995178
[TBL] [Abstract][Full Text] [Related]
42. Exercise-induced increases in oxidized low-density lipoprotein are associated with adverse outcomes in chronic heart failure.
Jorde UP; Colombo PC; Ahuja K; Hudaihed A; Onat D; Diaz T; Hirsh DS; Fisher EA; Tseng CH; Vittorio TJ
J Card Fail; 2007 Nov; 13(9):759-64. PubMed ID: 17996825
[TBL] [Abstract][Full Text] [Related]
43. Levels of circulating pro-angiogenic cells predict cardiovascular outcomes in patients with chronic heart failure.
Balconi G; Lehmann R; Fiordaliso F; Assmus B; Dimmeler S; Sarto P; Carbonieri E; Gualco A; Campana C; Angelici L; Masson S; Mohammed SA; Dejana E; Gorini M; Zeiher AM; Latini R;
J Card Fail; 2009 Nov; 15(9):747-55. PubMed ID: 19879460
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide.
Boffa GM; Zaninotto M; Sartor R; Mion M; Berton A; Pasqualetto C; Razzolini R; Plebani M
J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):758-64. PubMed ID: 19553828
[TBL] [Abstract][Full Text] [Related]
45. Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy.
Theodoropoulos TA; Bestetti RB; Otaviano AP; Cordeiro JA; Rodrigues VC; Silva AC
Int J Cardiol; 2008 Aug; 128(1):22-9. PubMed ID: 18258318
[TBL] [Abstract][Full Text] [Related]
46. [Prognostic value of discharge hemoglobin level in patients hospitalized for acute heart failure].
Sánchez-Torrijos J; Gudín-Uriel M; Nadal-Barangé M; Jacas-Osborn V; Trigo-Bautista A; Giménez-Alcalá M; Payá-Serrano R; Ridocci-Soriano F
Rev Esp Cardiol; 2006 Dec; 59(12):1276-82. PubMed ID: 17194423
[TBL] [Abstract][Full Text] [Related]
47. Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure.
Jankowska EA; Filippatos G; Ponikowska B; Borodulin-Nadzieja L; Anker SD; Banasiak W; Poole-Wilson PA; Ponikowski P
J Card Fail; 2009 Jun; 15(5):442-50. PubMed ID: 19477405
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of heart rate variability in patients with renal failure on hemodialysis.
Oikawa K; Ishihara R; Maeda T; Yamaguchi K; Koike A; Kawaguchi H; Tabata Y; Murotani N; Itoh H
Int J Cardiol; 2009 Jan; 131(3):370-7. PubMed ID: 18199499
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of QTc prolongation in adult Nigerians with chronic heart failure.
Kolo PM; Opadijo OG; Omotoso AB; Balogun MO; Araoye MA; Katibi IA
West Afr J Med; 2008 Apr; 27(2):69-73. PubMed ID: 19025017
[TBL] [Abstract][Full Text] [Related]
50. Relationship between elevated serum gamma-glutamyltransferase activity and slow coronary flow.
Sen N; Ozlü MF; Başar N; Ozcan F; Güngör O; Turak O; Malçok O; Cağli K; Maden O; Erbay AR; Demir AD
Turk Kardiyol Dern Ars; 2009 Apr; 37(3):168-73. PubMed ID: 19553739
[TBL] [Abstract][Full Text] [Related]
51. The association between blood pressure and mortality in patients with heart failure.
Lee TT; Chen J; Cohen DJ; Tsao L
Am Heart J; 2006 Jan; 151(1):76-83. PubMed ID: 16368295
[TBL] [Abstract][Full Text] [Related]
52. Predictors of mortality and hospitalization for cardiac causes in patients with heart failure and nonischemic heart disease: a subanalysis of the ALPHA study.
Anselmino M; De Ferrari GM; Massa R; Manca L; Tritto M; Molon G; Curnis A; Devecchi P; Sarzi Braga S; Bartesaghi G; Klersy C; Accardi F; Salerno-Uriarte JA;
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S214-8. PubMed ID: 19250099
[TBL] [Abstract][Full Text] [Related]
53. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
Yamaji M; Tsutamoto T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
Circ Heart Fail; 2009 Nov; 2(6):608-15. PubMed ID: 19919986
[TBL] [Abstract][Full Text] [Related]
54. Distribution, determinants, and prognostic value of gamma-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany.
Brenner H; Rothenbacher D; Arndt V; Schuberth S; Fraisse E; Fliedner TM
Prev Med; 1997; 26(3):305-10. PubMed ID: 9144754
[TBL] [Abstract][Full Text] [Related]
55. Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
Kim CH; Park JY; Lee KU; Kim JH; Kim HK
Diabetes Metab Res Rev; 2009 Jan; 25(1):64-9. PubMed ID: 19065605
[TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of incident complete left bundle branch block observed over a 40-year period.
Imanishi R; Seto S; Ichimaru S; Nakashima E; Yano K; Akahoshi M
Am J Cardiol; 2006 Sep; 98(5):644-8. PubMed ID: 16923453
[TBL] [Abstract][Full Text] [Related]
57. Telomere length and outcome in heart failure.
van der Harst P; de Boer RA; Samani NJ; Wong LS; Huzen J; Codd V; Hillege HL; Voors AA; van Gilst WH; Jaarsma T; van Veldhuisen DJ
Ann Med; 2010; 42(1):36-44. PubMed ID: 19941413
[TBL] [Abstract][Full Text] [Related]
58. Usefulness of admission gamma-glutamyltransferase level for predicting new-onset heart failure in patients with acute coronary syndrome with left ventricular systolic dysfunction.
Sarıkaya S; Aydın G; Yücel H; Kaya H; Yıldırımlı K; Başaran A; Zorlu A; Sahin S; Akyol L; Bulut M
Turk Kardiyol Dern Ars; 2014 Apr; 42(3):236-44. PubMed ID: 24769815
[TBL] [Abstract][Full Text] [Related]
59. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
Kenchaiah S; Pocock SJ; Wang D; Finn PV; Zornoff LA; Skali H; Pfeffer MA; Yusuf S; Swedberg K; Michelson EL; Granger CB; McMurray JJ; Solomon SD;
Circulation; 2007 Aug; 116(6):627-36. PubMed ID: 17638930
[TBL] [Abstract][Full Text] [Related]
60. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
